• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women suffering from ADHD face a difficult decision on whether to keep or stop taking ADHD medication during pregnancy and breast-feeding. There is a lack of information about how long-term exposure to these drugs could affect the foetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication during the uterus don't develop neurological disorders such as hearing or vision impairment seizures, febrile seizures or IQ impairment. The authors acknowledge that more high-quality studies are required.

Risk/Benefit Analysis

Women who are expecting and taking ADHD medication should evaluate the benefits of using it against the possible risks for the fetus. Physicians don't have the data needed to give clear guidelines but they can provide information on risks and benefits that assist pregnant women in making informed choices.

A study published in Molecular Psychiatry concluded that women who were taking ADHD medication in early pregnancy were not at higher risk of fetal malformations or structural birth defects. The researchers used a large population-based case-control study to evaluate the incidence of major structural birth defects in babies born to mothers who had taken stimulants during the early stages of pregnancy, as well as those who had not. Pediatric cardiologists and clinical geneticists reviewed the cases to ensure correct case classification and to minimize the possibility of bias.

However, the researchers' study had its limitations. The researchers were not able to, in the first place to distinguish the effects triggered by the medication from the disorder. This makes it difficult to know whether the limited associations observed in the exposed groups are due to medication use or confounding by comorbidities. Additionally the study did not examine the long-term effects of offspring on their parents.

The study did show that babies whose mothers had taken ADHD medication during pregnancy were at slightly higher risk of being admitted to the neonatal intensive care unit (NICU) than those who whose mothers did not take any medication or taken off their medication prior to or during pregnancy. This was due to central nervous system-related disorders, and the increased risk of admission did not appear to be affected by the type of stimulant medications were used during pregnancy.

Women who took stimulant ADHD medications during pregnancy also had a higher risk of having caesarean sections or the baby was not scoring well on the Apgar scale (less than 7). These increases didn't appear to be influenced by the type of medication that was used during pregnancy.

Researchers suggest that the small risks associated with the use ADHD medications used to treat adhd during early pregnancies can be offset by greater benefits to both baby and mother of continued treatment for the woman’s disorder. Physicians should discuss this with their patients and, if possible, help them develop strategies to improve their coping abilities that may minimize the impact of her disorder on her daily life and relationships.

Medication Interactions

As more women than ever are diagnosed with ADHD and treated with medication, the question of whether to keep or stop treatment during pregnancy is a question that more and more physicians have to face. These decisions are frequently made without clear and authoritative evidence. Instead, doctors must consider their own expertise and experience, as well as the experiences of other doctors, and the research on the subject.

The issue of potential risks for infants can be extremely difficult. A lot of studies on this topic are based on observational evidence instead of controlled research and their conclusions are often contradictory. The majority of studies focus on live-births, which could underestimate the severity of teratogenic effects that can lead to terminations or abortions of pregnancy. The study presented in the journal club addresses these shortcomings by analyzing the data from deceased and live births.

Conclusion Some studies have found an association between ADHD medications and certain birth defects However, other studies haven't found a correlation. The majority of studies show an unintended, or somewhat negative, impact. In each case an in-depth analysis of the benefits and risks should be conducted.

For women suffering from ADHD, the decision to stop taking medication can my general practitioner prescribe adhd medication (the full report) be difficult, if not impossible. In a recent article published in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can increase depression and feelings of loneliness. A decrease in medication could affect the ability to drive safely bipolar and adhd medication to perform work-related tasks which are vital aspects of normal life for those with ADHD.

She suggests that women who are unsure whether to continue taking medication or stop it due to their pregnancy should educate family members, coworkers and their friends about the condition, its effects on daily functioning, and the advantages of staying on the current treatment regimen. It can also help a woman feel more confident in her decision. It is important to note that some medications can be absorbed through the placenta therefore, if a patient decides to stop her ADHD medication during pregnancy and breastfeeding, she must be aware that traces of the medication could be passed on to the baby.

Risk of Birth Defects

As the use of ADHD drugs to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases, so do concerns about the effects that the drugs could have on fetuses. A study that was published in the journal Molecular Psychiatry adds to the existing knowledge on this subject. Using two massive data sets, researchers were able to analyze more than 4.3 million pregnancies and determine whether stimulant medications increased the risk of birth defects. Researchers discovered that, while the risk overall is low, first-trimester ADHD medication use was associated with slightly higher rates of certain heart defects, like ventriculoseptal defect.

The researchers of the study didn't discover any connection between early medication usage and other congenital anomalies such as facial deformities or club feet. The findings are in line with previous studies that have shown the presence of a small, but significant increase in the risk of developing cardiac malformations among women who started taking ADHD medications before the time of pregnancy. The risk increased in the latter stages of pregnancy, when a lot of women decided to stop taking their medication.

Women who took ADHD medication in the first trimester of pregnancy were also more likely to undergo a caesarean section, a low Apgar score following delivery, and a baby who required breathing assistance during birth. However the researchers of the study were not able to eliminate selection bias by limiting the study to women who did not have any other medical conditions that could have contributed to the findings.

Researchers hope their research will inform physicians when they meet pregnant women. The researchers suggest that, while discussing the risks and benefits are important, the decision on whether to continue or stop medication should be made in light of the severity of each woman's ADHD symptoms and her needs.

The authors warn that, while stopping adhd medication adults the medication is an option to think about, it isn't recommended because of the high incidence of depression and other mental disorders among women who are pregnant or have recently given birth. Further, research shows that women who stop taking their medication will have a difficult adjustment to life without them after the baby is born.

Nursing

The responsibilities of a new mom can be overwhelming. Women who suffer from ADHD can face severe challenges when they must deal with their symptoms, attend doctor appointments and prepare for the birth of their child and adjust to new routines. As such, many women decide to continue taking their safest adhd medication medication throughout the pregnancy.

The risk to breastfeeding infant is not too high since the majority of stimulant medication is absorbed through breast milk at low levels. However, the frequency of exposure to medication by the newborn can vary depending on dosage, how often it is administered and the time of the day the medication is administered. Additionally, individual medications enter the infant's system differently through the gastrointestinal tract as well as breast milk and the impact of this on a newborn infant is not fully understood.

Because of the lack of research, some doctors may be inclined to discontinue stimulant drugs during a woman's pregnancy. It's a difficult choice for the mother, who must weigh the advantages of taking her medication as well as the risk to the fetus. In the meantime, until more information is available, doctors should ask all pregnant patients about their history of ADHD and whether they plan or are taking to take medication during the perinatal period.

Numerous studies have proven that women can continue taking their ADHD medication safely during pregnancy and while breast-feeding. As a result, many patients opt to do this, and after consulting with their doctor, they have found that the benefits of keeping their current medication far outweigh any potential risks.

Women with ADHD who are planning to nurse should seek advice from a specialist psychiatrist before becoming pregnant. They should discuss their medication with their doctor and discuss the pros and cons of continuing treatment. This includes non amphetamine adhd medication-pharmacological strategies. Psychoeducation is also necessary to help pregnant women with ADHD recognize the signs and underlying disorder. They should also be educated about treatment options and build strategies for coping. This should be a multidisciplinary effort together with obstetricians, GPs, and psychiatrists. Pregnancy counseling should consist of a discussion of a treatment plan for the mother and the child, and monitoring for indicators of deterioration, and, if needed, adjustments to the medication regime.